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Exposure to ultraviolet radiation (UV) has multiple effects in skin.
These include deleterious events that are linked with increased
skin cancer risk (Kricker et al, 1994; Kripke, 1994) as well as
beneficial effects that include, according to several studies,
reduced risk of other cancers including those in colon, breast and
ovary (Blair and Fraumeni, 1978; Garland et al, 1980, 1990;
Studzinski and Moore, 1995; Ekman et al, 1997; Selby and
Mawer, 1999; McCarty, 2000). In this context, North American-
based studies linking latitude with prostate cancer mortality, have
been interpreted as showing that UV has a protective effect on
development of this cancer (Hanchette and Schwartz, 1992).
Indeed, the authors argued that the link of risk with latitude could
not be explained by other factors such as diet. 
The mechanism whereby UV might influence prostate cancer
risk is unclear though both vitamin D and parathyroid hormone
have been implicated (Studzinski and Moore, 1995; Selby and
Mawer, 1999; McCarty, 2000). Thus, 1,25 (OH)2 vitamin D has
effects on tumour cell proliferation, differentiation and spread and,
parathyroid hormone acts as a tumour promoter (Studzinski and
Moore, 1995; Haussler et al, 1998; McCarty, 2000). Indeed, UV
exposure may explain why subclinical rather than malignant
prostate disease is very common in older men. Thus, blood-borne
factors, whose concentration is determined by UV, could ensure
that tumours remain latent rather than progress to malignancy
(Hanchette and Schwartz, 1992). The concentration of such factors
will in part, be determined by skin colour and therefore, individual
ability to initiate pigment synthesis may mediate the harmful and
beneficial effects of exposure (Sturm et al, 1998; Rees and Healy,
1997). In particular, the synthesis of melanin is worthy of study as
it largely determines skin colour. The first rate-limiting steps of
melanin synthesis, hydroxylation of tyrosine to 3,4-dihydroxy-
phenylalanine and its dehydrogenation to dopaquinone are
catalyzed by tyrosinase (TYR) under the influence of melanocyte
stimulating homone (Sturm et al, 1998; Oetting and King, 1999).
This hormone acts via the melanocortin-1 receptor (MC1R). Both
genes demonstrate polymorphisms with functional consequences;
some mutations of TYR cause albinism (Oetting and King, 1999)
and MC1R variants are associated with hair colour and skin type
(Valverde et al, 1995; Rees and Healy, 1997; Box et al, 1997;
Abel-Malek et al, 1999; Palmer et al, 2000). Vitamin D is also
important. Its metabolites are formed in skin following UV expo-
sure and can promote differentiation and inhibit proliferation of
prostate cancer cells (Haussler et al, 1998). Synthesis of such
metabolites will fall with increased pigmentation. Further, several
studies have shown associations between vitamin D receptor
(VDR) genotypes and prostate cancer risk (Taylor et al, 1996;
Ingles et al, 1997). 
We now describe studies in prostate cancer cases and benign
prostatic hypertrophy (BPH) controls to determine whether
disease risk is mediated by polymorphism in VDR (Taql and Fokl
variants), TYR (codon 192 variants) and MC1R (Arg151Cys,
Arg160Trp, Val92Met, Asp294His, Asp84Glu alleles). The influ-
ence of these genes may depend on the amount of UV exposure
received. Accordingly, we also assessed acute and chronic expo-
sure using a questionnaire that has been independently validated
(Harvey et al, 1996a, 1996b; Ramsay et al, 2000). 
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MATERIALS AND METHODS 
Patients 
We recruited, between October 1999 and May 2000, 210 prostate
cancer cases and 155 BPH controls. They were unrelated,
Northern European Caucasians from urology clinics in the North
Staffordshire Hospital. Because definitive diagnosis of prostate
cancer and BPH can be difficult, we established inclusion and
exclusion criteria for these groups. Histological evidence of
prostatic adenocarcinoma was obtained in 190 patients. In 20
severely ill cases with clinically obvious prostate cancer, it was
considered unethical to subject patients to the potential morbidity
of a biopsy. These cases had a clinically malignant prostate gland
on digital rectal examination, positive bone scan and prostatic
specific antigen levels above 30 ng/ml (age-related reference
range up to 6.5 ng/ml). The proportions of cancer cases with well,
moderately and poorly differentiated tumours (WHO grade) was
as expected. Similarly, using the TNM staging system, local T
stage and metastatic state at presentation were typical. BPH
patients had a serum prostatic specific antigen level in the age-
related reference range and a benign digital rectal examination.
Histological confirmation of BPH was obtained in 123 subjects.
The North Staffordshire Hospital Ethics Committee approved the
study and informed consent was obtained from all patients. The
BPH comparison group was chosen because the diagnosis of BPH
largely allows exclusion of concurrent prostate cancer. 
Assessment of UV exposure 
All subjects completed a validated questionnaire (Harvey et al,
1996a, 1996b; Ramsay et al, 2000) that recorded; (i) Childhood
sunburning, defined as erythema for more than 48 h or blistering.
This parameter was scored as yes/no and the number of recalled
sunburning events was recorded. (ii) Adult sunbathing score
calculated as follows; the extent of sunbathing was recorded as
never, rarely, occasionally and frequently (scored 1, 2, 3 and 4
units respectively) in three age categories (20–39 years, 40–59
years and above 60 years). The score was obtained by adding the
units from the three age categories. (iii) History of regular foreign
holidays in a sunny country with mean weeks/year. (iv) Daily sun
exposure (weekdays and weekends considered separately in the
three age categories shown above and combined to give total
cumulative exposure). (v) Proportion of working life spent
outdoors. (vi) History of residence in a hot country for more than 6
months. Skin type (Ramsay et al, 2000), hair and eye colour were
recorded. 
Genotype identification 
DNA was extracted using phenol-chloroform from 5 ml blood.
The A→ C change in exon 1 (codon 192) of TYR was identified as
described (Giebel and Spritz, 1990). PCR-RFLP assays were used
to identify VDR alleles with exon 2 (Fok1) and exon 9 (Taq1) vari-
ants (Hutchinson et al, 2000). MC1R Arg151Cys and Arg160Trp
variants were detected using primers 5′ -TCTCCATCTTCTACG-
CATTG-3′ and 5′ -GCCAGCATGTGGACGTACAG-3′ to amplify
a 202 bp product. PCR conditions were 95˚C (2 min) and 35
cycles of 95˚C (1 min), 55˚C (1 min), 72˚C (1 min), followed by
72˚C (3 min). Arg151Cys was identified by digestion with BsrDl
(65˚C, 18 h) and products were examined after electrophoresis in
2% agarose. Arg151/Arg151 and Cys151/Cys151 subjects had frag-
ments of 180 bp and 22 bp and, 202 bp respectively. Arg160Trp
was identified by digestion with Sacll (37˚C, 18 h), and products
examined in 3% agarose. Arg160/Arg160 and Trp160/Trp160 subjects
had fragments of 156 bp and 46 bp and, 202 bp. Val92Met,
Asp294His and Asp84Glu variants were identified as described
(Ichii-Jones et al, 1998). 
Statistical methods 
Data was analysed using Stata version 6 for Windows (State
Corporation, College Station, TX). All tests of significance were
two sided. Student’s  t-test was used to demonstrate an age
difference and logistic regression was used to compare frequencies
of parameters in cases and controls. Step-wise logistic regression,
with a threshold for inclusion/exclusion of a variable of P = 0.1,
was used to identify the best set of predictors. We recognize that
examination of eight genotypes for links with phenotype risks
identification of false associations. However, correction for
multiple testing may increase the risk of type II errors (Perneger,
1998). Accordingly, we present uncorrected P-values but recog-
nize our exploratory findings require confirmation in another case
group. This approach minimizes loss of true positive results but
allows false positive results to be identified (Perneger, 1998;
Cuzick, 1999). 
RESULTS 
VDR, TYR and MC1R genotypes and prostate cancer
risk 
A complete genotype data set was obtained from all but 2 subjects
(1 from each group). These DNA samples were refractory to
amplification in all the PCR assays. Logistic regression analysis
was used to identify associations between the eight individual
polymorphisms and susceptibility to prostate cancer (Table 1). As
the mean age at diagnosis of cases (70.6 years) was significantly
greater (P < 0.001) than that of controls (67.0 years), we included
correction for this imbalance in all logistic regression models. For
the MC1R loci, we compared frequencies of homozygotes for the
wild type allele against combined frequencies of heterozygotes
and homozygotes for the mutant allele (Table 1). This approach
was used because mutant allele frequencies are generally small
and, heterozygotes as well as homozygotes for mutant alleles are
associated with sun-sensitive phenotypes (13). VDR and TYR
genotypes were factorized as shown (Table 1). We first analysed
each gene individually, correcting only for age at diagnosis in the
model. Six polymorphisms showed no significant association with
prostate cancer risk (data not shown). However, MC1R
Arg160/Arg160 homozygotes were at increased risk (P = 0.027, odds
ratio = 1.94, 95% CI = 1.08–3.49) while TYR A2/A2 homozy-
gotes were at reduced risk (P = 0.033, odds ratio = 0.48, 95% 
CI = 0.25–0.94). 
We next determined whether the associations of individual geno-
types with risk were influenced by inclusion of the parameters of
UV exposure derived from the questionnaire. These were; history
of childhood sunburning, adult sunbathing score, history of regular
foreign holidays, history of living in a sunny country for > 6
months, ratio of occupational time spent indoors/outdoors, skin
type, hair and eye colour. We also studied cumulative UV exposure.
In this context, unpublished studies in these cases and controls1506 CJ Luscombe et al
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showed that cumulative exposure in the lowest quartile (less than
1639 days of lifetime exposure) was a better predictor of prostate
cancer risk than total cumulative exposure (Luscombe et al, 2001).
Accordingly, in further logistic regression models, we included sun
exposure in the lowest quartile instead of total cumulative expo-
sure. MC1R Arg160/Arg160 and TYR A2/A2 remained significantly
associated with cancer risk (Table 1). 
We further confirmed these associations by using stepwise
logistic regression analysis to identify the best set of predictors of
prostate cancer in the presence of other variables. The model
included all parameters derived from the questionnaire and the
eight genotypes and age at diagnosis. Table 2 shows that four UV
predictors and, MC1R Arg160/Arg160 and TYR A2/A2 were all
significantly associated with prostate cancer risk. Childhood
sunburning, on the basis of its odds ratio (0.13) had the greatest
influence. The values of the odds ratio for the genotypes were
similar to those of the other UV predictors suggesting equal impact. 
Genotype associations in patients stratified by
exposure 
We next determined whether the association of TYR A1A2 and
A2A2 with cancer risk was more evident in cases stratified into
sub-groups based on quartiles of total cumulative exposure. We
found that in 46 BPH controls whose cumulative exposure was in
the highest quartile, 44 subjects were TYR A1A2 or A2A2
(95.7%). In the corresponding 47 prostate cancer cases, 32
subjects were TYR A1A2 or A2A2 (68.1%). Logistic regression
analysis demonstrated that these proportions were significantly
different (TYR A1A2, P = 0.006, A2A2 P = 0.003, Table 3) even
after correction for the UV parameters found to be significant in
the step-wise routine (childhood sunburning, adult sunbathing
score and holidays abroad). By contrast, the frequencies of these
genotypes were not significantly different (P = 0.98, P = 0.45,
respectively) in 162 cases and 108 controls whose exposure was in
the first, second or third quartiles. Table 3 shows that the associa-
tion of MC1R Arg160/Arg160 with increased risk was found in
patients from both quartiles 1–3 and 4 though the link only
achieved significance in subjects with exposure in quartiles 1–3. 
DISCUSSION 
The causes of prostate cancer are unclear though data in twins
shows that environmental factors account for over 50% of risk
(Lichtenstein et al, 2000). However, the impact on risk, of
suggested causative factors including diet and occupation are
relatively modest (odds ration < 2.5) (Ekman et al, 1997).
Latitude and by inference, UV exposure have also been impli-
cated (Blair and Fraumeni, 1978; Hanchette and Schwartz,
1992). To further explore this hypothesis we speculated that
genes associated with host response to UV would be associated
with susceptibility to this cancer. We used BPH patients as
controls because the condition appears part of normal ageing and
is not associated with increased prostate cancer risk (Young et al,
2000). Further, diagnosis of BPH, requires exclusion of prostate
cancer and as screening for this cancer is not advised in the
United Kingdom, BPH patients are the only available group that
is unlikely to have this malignancy. Quantification of UV expo-
sure is difficult as data is often collected decades after exposure
events from elderly patients. It is however, essential if the effects
of UV on cancer risk are to be assessed. Various questionnaires
Table 1 Comparison of genotype frequencies in cases and controls 
Controls (%) Cases (%) P-value      Odds ratio 95% CI 
MC1R
Arg151/Arg151 104 (67.5) 152 (72.7) 0.356 1.29 0.75–2.24 
Arg151/Cys151 and Cys151/Cys151 50 (32.5) 57 (27.3) reference 1 N/A 
Arg160/Arg160 122 (79.2) 184 (88.0) 0.023 2.14 1.11–4.12 
Arg160/Trp160 and Trp160/Trp160 32 (20.8) 25 (12.0) reference 1 N/A 
Val92/Val92 129 (83.8) 170 (81.3) 0.523 0.82 0.43–1.55 
Val92/Met92 and Met92/Met92 25 (16.2) 39 (18.7) reference 1 N/A 
Asp294/Asp294 144 (93.5) 194 (92.8) 0.587 0.70 0.19–2.56 
Asp294/His294 and His294/His294 10 ( 6.5) 15 ( 7.3) reference 1 N/A 
Asp84/Asp84 148 (96.1) 202 (96.7) 0.374 0.64 0.24–1.70 
Asp84/Glu84 and Glu84/Glu84 6 ( 3.9) 7 ( 3.3) reference 1 N/A 
Tyrosinase
A1A1 18 (11.7) 41 (19.6) reference 1 N/A 
A1A2 71 (46.1) 101 (48.3) 0.245 0.65 0.31–1.35 
A2A2 65 (42.2) 67 (32.1) 0.033 0.44 0.21–0.94 
VDR
FF 65 (42.2) 85 (40.7) reference 1 N/A 
Ff 65 (42.2) 92 (44.0) 0.775 0.93 0.55–1.57 
ff 24 (15.6) 32 (15.3) 0.505 0.78 0.37–1.63 
TT 57 (37.0) 70 (33.5) reference 1 N/A 
Tt 67 (43.5) 110 (52.6) 0.996 1.00 0.57–1.73 
tt 30 (19.5) 29 (13.9) 0.266 0.66 0.32–1.40 
Logistic regression analysis was used to compare the frequencies of each individual genotype in a model that
included age at diagnosis, childhood sunburning, adult sunbathing score, positive holiday history, proportion of
occupation spent indoor/outdoor, living abroad for more than 6 months, skin type, eye and hair colour and UV
exposure in the lowest quartile. Ultraviolet radiation and prostate cancer risk 1507
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have been used to assess exposure. We used a questionnaire that
has been validated in independent studies in skin cancer patients
(Harvey et al, 1996a,b) and, renal transplant recipients (Ramsay
et al, 2000). 
The VDR, TYR and MC1R genes have a presumed role in host
response to UV. We recognize that in highly allelic genes, selection
of alleles for study is problematical. In this regard, we selected vari-
ants on the basis of presumed function and frequency. Clearly other
alleles at these genes could demonstrate strong associations with
prostate cancer risk though in many cases their frequencies are
small. Each of the alleles studied is therefore, regarded as a marker
on chromosome 12q (VDR), 11q (TYR) or 16q (MC1R) that could
be in linkage disequilibrium with the true candidate gene. Further,
we reported associations between individual genotypes and suscepti-
bility and cannot infer that particular genotypes define an individual
response to UV. Indeed, some subjects classified as homozygotes for
wild type alleles may be homozygous or compound heterozygous
for variant alleles not included in our series. It is noteworthy
however, that we found associations between MC1R genotypes 
and skin type. Thus, the frequencies of MC1R Arg160/Arg160,
Table 2 Stepwise logistic regression analysis to identify the best set of predictors for prostate
cancer risk 
Predictor P-value Odds ratio 95% Cl 
Childhood sunburning < 0.001 0.13 0.06–0.31 
Age at diagnosis < 0.001 1.07/year 1.03–1.10 
Adult sunbathing score < 0.001 0.84/unit 0.77–0.91 
Foreign holidays 0.003 0.44 0.26–0.76 
Lowest 25% of cumulative exposure 0.005 2.37 1.30–4.34 
MC1R Arg160/Arg160 0.014 2.24 1.18–4.24 
Tyrosinase: A2A2 0.037 0.50 0.36–0.97 
The stepwise model included: history of childhood sunburning, age at diagnosis, adult
sunbathing score, history of regular foreign holidays, Lowest 25% of cumulative exposure,
history of living in a sunny country for > 6 months, ratio of occupational time spent indoors and
outdoors, hair colour, eye colour and skin type. The following genotypes were also included:
MC1R; Arg151Cys (Arg151/Arg151 vs Arg151/Cys151 and Cys151/Cys151), Arg160Trp (Arg160/Arg160
vs Arg160/Trp151 and Trp151/Trp151), Val92Met (Val92/Val92 vs Val92/Met92 and Met92/Met92),
Asp294His (Asp294/Asp294 vs Asp294/His294 and His294/His294), Asp84Glu (Asp84/Asp84 vs
Asp84/Glu84 and Glu84/Glu84), TYR A2A2 (A1 as reference) and VDR; Fok I (FF as reference)
and Taq I (TT as reference). 
Table 3 Association of TYR genotypes with prostate cancer risk in cases stratified by UV exposure 
P-value Odds ratio 95% Cl 
TYR genotypes
(i) association of TYR genotypes with prostate cancer risk in the 93 cases and BPH controls who received the highest quartile of UV exposure: 
TYR A1A2 0.006 0.075 0.011–0.48 
TYR A2A2 0.003 0.055 0.008–0.37 
Age at diagnosis 0.698 1.01/year 0.94–1.09 
Holidays in hot climates 0.837 1.12 0.35–3.71 
Childhood sun burning 0.027 0.039 0.002–0.69 
Adult sunbathing score < 0.001 0.68/unit 0.56–0.83 
(ii) association of TYR genotypes with prostate cancer risk in the 270 cases and BPH controls who received UV exposure in quartiles 1–3: 
TYR A1A2 0.98 0.99 0.44–2.20 
TYR A2A2 0.47 0.73 0.32–1.67 
Age at diagnosis < 0.001 1.07/year 1.03–1.11 
Holidays in hot climates 0.005 0.41 0.22–0.77 
Childhood sun burning 0.027 0.17 0.07–0.42 
Adult sunbathing score < 0.001 0.88/unit 0.79–0.97 
MC1R genotypes
(i) association of MC1R genotypes with prostate cancer risk in the 93 cases and BPH controls who received the highest UV exposure (quartile 4): 
MC1R Arg160/Arg160 0.33 1.95 0.51–7.47 
Age at diagnosis 0.52 1.02/year 0.95–1.10 
Holidays in hot climates 0.76 0.84 0.28–2.52 
Childhood sun burning 0.02 0.072 0.008–0.66 
Adult sunbathing score < 0.001 0.72/unit 0.61–0.85 
(ii) association of MC1R genotypes with prostate cancer risk in the 270 cases and BPH controls who received UV exposure in quartiles 1–3: 
MC1R Arg160/Arg160 0.029 2.26 1.08–4.67 
Age at diagnosis 0.001 1.06/year 1.03–1.10 
Holidays in hot climates 0.002 0.37 0.20–0.70 
Childhood sun burning < 0.001 0.16 0.06–0.39 
Adult sunbathing score 0.015 0.88/unit 0.80–0.98 
The data show a comparison of the frequencies of genotypes and UV-derived parameters in prostate cancer cases and BPH controls using
logistic regression analysis. The model included the parameters shown. 1508 CJ Luscombe et al
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Arg151/Arg151 and Asp84/Asp84 in cases and controls increased
through skin types 1– 4 (data not shown). By contrast, Val92/Val92
and Asp294/Asp294 were not associated with skin type. Since only four
controls and two cases had red hair, it was not possible to assess
whether MC1R genotypes were associated with hair colour. 
We studied two of the five polymorphic sites identified in the
VDR. Allelism at the Fok1 site alters the upstream start codon
resulting in production of a shortened protein from the F allele
(Haussler et al, 1998). The Taq1 restriction site is in linkage disequi-
librium with three other 3′ -UTR polymorphisms; Bsm1, Apa1 and a
poly(A) tail microsatellite. These variants may also be functionally
significant because the length of the poly(A) repeat affects mRNA
stability. TYR is highly allelic with more than 90 alleles identified
(Oetting and King, 1999). We studied the allele resulting from an
A→ C change in exon 1. While this change has not been shown to
have functional consequences, the A1 and A2 alleles have similar
frequencies (0.44 and 0.56 in cases) and are useful markers. The
MC1R is also highly polymorphic with more than 20 alleles identi-
fied (Sturm et al, 1998; Rees and Healy, 1997; Valverde et al, 1995;
Palmer et al, 2000; Box et al, 1997; Abel-Malek et al, 1999). We
studied Arg151Cys, Arg160Trp and Asp294His, which are linked
with red hair, Val92Met which has been linked with skin type and
Asp84Glu which has been associated with malignant melanoma risk
in one but not other studies (Sturm et al, 1998; Rees and Healy,
1997; Valverde et al, 1995; Palmer et al, 2000; Box et al, 1997;
Abel-Malek et al, 1999; Ichii-Jones et al, 1998). 
We found that only MC1R Arg160/Arg160 and TYR A2A2 were
significantly associated with prostate cancer risk. These analyses
were performed with individual genes and, with and without,
inclusion of UV parameters in the logistic regression models.
Homozygosity for MC1R Arg160 was associated with increased
risk (odds ratio = 2.18) while homozygosity for TYR A2 allele was
linked with reduced risk of cancer (odds ratio = 0.42). Neither the
other MC1R genotypes nor the VDR sites were linked with risk. A
stepwise routine that included all genotypes and parameters from
the UV questionnaire confirmed these findings. While there are no
published data on associations between TYR or MC1R genotypes
and prostate cancer risk, links between VDR Taq1 variants have
been reported (odds ratio for tt 0.34) (Taylor et al, 1996). We found
that VDR tt was linked with lower risk (odds ratio 0.66) than TT
though the difference was not significant (P = 0.252). The reason
for this difference is unclear but may reflect differences in the rela-
tive impact of environmental and genetic factors in these popu-
lations. We next determined whether associations between
genotypes and prostate cancer risk were dependent on UV expo-
sure. We found that the protective effect of TYR genotypes, found
in the total group, reflects an association with risk in subjects with
the highest quartile of exposure. Though the functional conse-
quences of the polymorphism are unknown, we speculate that the
variant allele is associated with less efficient production of
melanin and reduced pigmentation. Thus, the beneficial effects of
high UV exposure will be more effectively transmitted systemi-
cally. It is unclear why this link is not found in subjects who
received less UV exposure. By contrast the link of MC1R
Arg160/Arg160 with risk was found in subjects with exposure in
quartiles 1–3 and 4 though the association in subjects with greatest
exposure was not significant. No associations between VDR geno-
types and risk were found in these groups. 
Polymorphism in various genes including VDR, androgen
receptor and prostatic specific antigen, has been linked with
prostate cancer susceptibility (Taylor et al, 1996; Ingles et al, 1997;
Xue et al, 2000). Our data show for the first time, that allelism in
genes linked with skin pigment synthesis is associated with risk.
We recognize that while UV appears critical in the development of
skin cancers, its role in determining susceptibility to prostate cancer
is speculative (Studzinski and Moore, 1995). Nonetheless, while
our data are preliminary and require confirmation in a separate case
group, they demonstrate some internal consistency. Thus, aspects
of chronic and acute UV exposure and, genes associated with
response to UV were associated with risk. Some associations
demonstrated small P values and significance would be observed
even after correction for multiple testing using a rigorous approach
such as that described by Bonferroni (Perneger, 1998). 
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